Related Experiment Video
Updated: Feb 14, 2026
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[The new 2017 European society of cardiology (ESC) guidelines: important changes for introduction into clinical
V V Fomin1, A A Svistunov1, D A Napalkov1
1I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia.
Insights
The 2017 European Society of Cardiology guidelines offer updated recommendations for dual antiplatelet therapy (DAT), ST-segment elevation myocardial infarction (STEMI) treatment, and valvular heart disease management. This analysis discusses key diagnostic and treatment advancements.
Area of Science:
- Cardiology
- Clinical Guidelines
Background:
- The European Society of Cardiology (ESC) released updated guidelines in 2017.
- These revisions cover critical areas including dual antiplatelet therapy (DAT), ST-segment elevation myocardial infarction (STEMI), valvular heart disease, and peripheral artery disease.
Purpose of the Study:
- To provide an independent analysis and discussion of the 2017 ESC guidelines.
- To highlight key updates in diagnosis and treatment for specific cardiovascular conditions.
Main Methods:
- Review and critical analysis of the updated 2017 ESC guidelines.
- Focus on specific recommendations for DAT, STEMI, valvular heart disease, and peripheral artery disease.
Main Results:
- Updated DAT recommendations emphasize therapy timing and drug selection.
- Revised STEMI treatment guidelines specify percutaneous coronary intervention timing, revascularization strategies, fibrinolytic therapy, and lipid-lowering approaches.
- New recommendations for peripheral artery atherosclerosis include antiplatelet or anticoagulant selection based on clinical context.
Conclusions:
- The 2017 ESC guidelines introduce significant updates for managing complex cardiovascular conditions.
- These revisions offer refined approaches to antiplatelet therapy, acute myocardial infarction treatment, and peripheral artery disease management.
Abstract:
The paper gives an overview of the European Society of Cardiology (ESC) guidelines updated in 2017. The revised and amended guidelines for areas, such as dual antiplatelet therapy (DAT), treatment of patients with ST-segment elevation myocardial infarction (STEMI), and management of patients with valvular heart disease and peripheral artery disease, were presented in late summer of this year. The authors of this paper present an independent analysis and discussion of new data on the key issues of diagnosis and treatment in patients in the above areas. The recommendations on DAT pay special attention to the timing of the therapy and to the choice of its drugs. The updated data on the treatment of patients with STEMI accurately determine the time to percutaneous coronary interventions, approaches to revascularization; the updates touch upon fibrinolytic therapy and new approaches to lipid-lowering therapy too. Recommendations for the management of patients with peripheral artery atherosclerosis propose for the first time a section devoted to the choice of antiplatelet therapy (an antiaggregant and/or an anticoagulant) depending on the clinical situation.
More Related Videos
11:50Clinical Practice Protocol of Creative Music Therapy for Preterm Infants and Their Parents in the Neonatal Intensive Care Unit
Published on: January 7, 2020
08:55A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
Published on: April 17, 2019
Related Concept Videos
01:23Guidelines for Sketching a Curve
01:11Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
01:30Guidelines for Nursing Documentation I
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
01:26Guidelines for Nursing Documentation II
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
01:06Legal Guidelines for Documentation
01:18Guidelines and Strategies for Safe Computer Charting
Maintain Confidentiality and Security: